NCT00414323View on ClinicalTrials.gov

Evaluation of the Effects of Duloxetine on Norepinephrine

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

May 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Duloxetine

DRUG

Escitalopram

DRUG

Placebo

Trial Locations (2)

78229

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Antonio

91206

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00414323 - Evaluation of the Effects of Duloxetine on Norepinephrine | Biotech Hunter | Biotech Hunter